5m vaccine doses arrive today
Govt allows anti-body test
24th January, 2021 10:14:01
A consignment of five million doses of Oxford-AstraZeneca ‘Covishield’ vaccine manufactured by the Serum Institute of India (SII) will arrive from India today.
This will be the first consignment of the 30 million doses of ‘Covishield’ purchased from India. Bangladesh would get the vaccines in six phases as every consignment will carry 5 million vaccine doses per month.
The government has also allowed antibody test to determine whether someone has developed antibodies against the virus.
Talking to reporters on Sunday, Health Minister Zahid Maleque said 50 lakh doses of Covid-19 vaccine, purchased from India s Serum Institute, will reach Dhaka on Monday.
Bharat Biotech applies for COVID-19 vaccine trials in Bangladesh medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
[BenarNews]
Bangladesh received its first shipment of coronavirus vaccines – a gift from the Indian government – after Chinese state-owned Sinovac late last year withdrew from trials in the country following Dhaka’s refusal to co-fund phase-three tests for its vaccine.
Bangladesh is preparing to begin inoculations in the first week of February after receiving India’s gift of 2 million doses of the Covishield vaccine, Health Minister Zahid Maleque said. The vaccine was developed through a partnership between drug maker AstraZeneca and Oxford University, and produced by the Serum Institute of India (SII).
“Today we have received 20 lakh (2 million) doses of vaccines as a gift from India. It is proven that friendly countries help each other. India helped us with vaccines the way they helped us during our war of independence,” Maleque said, after Indian High Commissioner Vikram K. Doraiswami handed over the vaccine shipment to Bangladesh during a cere
Ganashasthaya gets approval for Covid-19 antibody kit The New Nation
Staff Reporter :
Ganashasthaya Kendra (GK) on Thursday got the approval for trial of its Covid-19 antibody kit from the Bangladesh Medical Research Council (BMRC).
GK founder Dr Zafrullah Chowdhury confirmed the matter.
Without giving any date, he said that the trial would be held at ICDDR,B. The trial might begin within a week, he said.
Earlier, a trial of the kit was held at Bangabandhu Sheikh Mujib Medical University in June.
The government authorities did not approve the kit for its use, citing the result as inconclusive.
GK developed the low-cost kit shortly after Bangladesh confirmed the first case of Covid-19 virus infection in March.
Senior Correspondent,
bdnews24.com
Published: 22 Jan 2021 11:55 PM BdST
Updated: 22 Jan 2021 11:55 PM BdST A man rides his motorbike past a parked bus of India s biotechnology company Bharat Biotech outside its office in Hyderabad, India July 3, 2020. REUTERS/Stringer
India’s Bharat Biotech has sought approval from the authorities to hold clinical trials of its coronavirus vaccine candidate COVAXIN in Bangladesh. );
}
The company applied for the approval around two weeks ago, said Dr Syed Modasser Ali, the chairman of Bangladesh Medical Research Council.
The application for the phase three trial has been sent to the council’s Ethical Review Committee for scrutiny, he said on Friday.